Showing results (381-390 of 1,135) with videos related to
Sort By:
Pageof 114
Journal of Hepatocellular Carcinoma|December 18, 2025
Evaluation of Combined Lipiodol and Epirubicin-Loaded Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatocellular CarcinomaDongqiang Song, Xueyi Feng, Yingting Zhou, et al.Journal of Hepatocellular Carcinoma|December 19, 2025
Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune InfiltrationMaimaitiming Aimaiti, Dilimulati Maimaitituxun, Xiaokaiti Yilihaer, et al.Journal of Hepatocellular Carcinoma|February 17, 2025
Assessment of Tumor Burden Score as a Feasible and Reliable Tool for Prognosis Prediction for Hepatocellular Carcinoma Undergoing Hepatectomy: A Multicenter, Retrospective StudyRenguo Guan, Zehao Zheng, Min Deng, et al.Journal of Hepatocellular Carcinoma|December 25, 2024
Transarterial Chemoembolization Plus Camrelizumab and Rivoceranib versus Camrelizumab and Rivoceranib Alone for BCLC Stage C Hepatocellular CarcinomaWen-Jie Zhou, Jin-Tao Huang, Xin Lu, et al.Journal of Hepatocellular Carcinoma|December 24, 2024
Roles and Mechanisms of Ferroptosis in Sorafenib Resistance for Hepatocellular CarcinomaRuyuan Liu, Huanyu Cui, Di Li, et al.Journal of Hepatocellular Carcinoma|February 11, 2025
Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver RemnantShenyu Zhang, Ruipeng Song, Changlong Hou, et al.Journal of Hepatocellular Carcinoma|January 29, 2025
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 InhibitorsYujing Xin, Ning Liu, Gang Peng, et al.Journal of Hepatocellular Carcinoma|January 30, 2025
Design and Mechanism Study of 6c, a Novel Artesunate Derivatives, for Anti-Hepatocellular CarcinomaShang-Shang XiongJournal of Hepatocellular Carcinoma|January 28, 2025
Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular CarcinomaLiting Zhong, Weiwei Peng, Jingyuan Sun, et al.Journal of Hepatocellular Carcinoma|February 24, 2025
Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular CarcinomaYuxia Li, Ruijiao Lu, Xieyidai Abuduhailili, et al.Pageof 114